CUE
CUE
NASDAQ · Biotechnology

Cue Biopharma Inc

Biotech Stocks Healthcare Stocks
$34.20
+3.12 (+10.04%)
As of Aug 15, 2:29 AM ET ·
Analyst Consensus
Strong Buy
5
Analysts
Moderate
Coverage
Buy 4 80%
Hold 1 20%
Sell 0 0%
Price Target
Analyst Price Target -53.9% upside
Low Target $10.91
Average Target $15.75
High Target $18.65
Current Price $34.20
Current
$34.20
Target
$15.75
$10.91 $15.75 avg $18.65
Scenario Analysis
Bear Case
$10.91
-68.1%
Low target
Base Case
$15.75
-53.9%
Avg target
Bull Case
$18.65
+-45.5%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$45.50
-24.8% from high
52-Week Low
$4.97
+588.1% from low
Target vs 52W High
$15.75
-65.4% vs high
Next Earnings Report
Aug 18, 2026
2d
until earnings
EPS Est: $-1.71
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
 Buy 43 67% $91.45 -56.4%